IOL Chemicals and Pharmaceuticals Ltd
Fri 11/07/2025,15:59:50 | NSE : IOLCP
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 91.05
Previous Close
₹ 91.05
Volume
1227006
Mkt Cap ( Rs. Cr)
₹2676.38
High
₹ 94.39
Low
₹ 90.85
52 Week High
₹ 107.54
52 Week Low
₹ 57.50
Book Value Per Share
₹ 56.53
Dividend Yield
0.87
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on IOL Chemicals and Pharmaceuticals Ltd
Your Vote -
Buy
62.95%
Hold
1.92%
Sell
35.13%
62.95%
780 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
91.18
125
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
125
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts IOL Chemicals and Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
IOL Chemicals and Ph - Credit Rating- Revision
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Credit Rating
-
IOL Chemicals and Ph - Trading Window-XBRL
-
IOL Chemicals and Ph - Trading Window
-
IOL Chemicals and Ph - General Updates
-
IOL Chemicals and Ph - REACH Registration For Acetic Anhydride
-
IOL Chemicals and Ph - General Updates
-
IOL Chemicals and Ph - IOL Awarded Ecovadis Silver Medal - Ranks Among The Top 15% Companies Globally
-
IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
IOL Chemicals and Ph - Investor Presentation
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Investor Presentation
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Change in Management
-
IOL Chemicals and Ph - Press Release
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
IOL Chemicals and Ph - Board Meeting Outcome for Outcome Of The Board Meeting Dated 16Th May 2025
-
IOL Chemicals and Ph Q4 net profit up 12.17% at Rs 31.62 cr
-
IOL Chemicals and Ph - Audited Financial Results For The Quarter And Year Ended 31St March 2025
-
IOL Chemicals and Ph - Outcome of Board Meeting
-
IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates
-
IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
IOL Chemicals and Ph - Board Meeting Intimation
-
IOL Chemicals and Ph - Board Meeting Intimation for Notice Of The Board Meeting
-
IOL Chemicals and Ph - General Updates
-
IOL Chemicals and Ph - General Updates
-
IOL Chemicals and Ph - Intimation Under SEBI (LODR) Regulations, 2015 - CDE, China Approved 'Ibuprofen'
-
IOL Chemicals and Ph - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio
-
IOL Chemicals and Ph has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
IOL Chemicals and Ph - Disclosure under SEBI Takeover Regulations
-
IOL Chemicals and Pharmaceuticals
-
IOL Chemicals and Pharmaceuticals
-
IOL Chemicals
-
IOL Chemicals gets European drug regulator nod to export Paracetamol
-
IOL Chem gets patent for preparation of Sartan drugs of Formula I
Key fundamentals
Evaluate the intrinsic value of IOL Chemicals and Pharmaceuticals Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1804.45 | 1644.09 | 1586.18 | 1433.02 | 1260.43 |
| Liabilities | 1804.45 | 1644.09 | 1586.18 | 1433.02 | 1260.43 |
| Equity | 58.71 | 58.71 | 58.71 | 58.71 | 58.71 |
| Gross Profit | 202.17 | 231.52 | 226.52 | 256.28 | 591.84 |
| Net Profit | 101 | 135.42 | 139.98 | 165.66 | 444.56 |
| Cash From Operating Activities | 178.68 | 290.76 | 123.14 | 91.04 | 379.78 |
| NPM(%) | 4.85 | 6.34 | 6.31 | 7.58 | 22.6 |
| Revenue | 2079.21 | 2132.79 | 2217.11 | 2184.02 | 1966.98 |
| Expenses | 1877.04 | 1901.27 | 1990.59 | 1927.74 | 1375.14 |
| ROE(%) | 6.08 | 8.16 | 8.43 | 9.98 | 26.79 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 18 Feb 2025 | 4 | 40 | 0.88 | 356.7 |
| 16 Feb 2024 | 5 | 50 | 0.88 | 443.15 |
| 17 Feb 2023 | 4 | 40 | 0.88 | 325.4 |
| 15 Feb 2022 | 4 | 40 | 0.88 | 447.9 |
| 08 Sep 2021 | 2 | 20 | 0.88 | 700.85 |
| 17 Nov 2020 | 4 | 40 | 0.88 | 691.55 |
| 18 Mar 2020 | 3 | 30 | 0.88 | 232.75 |
Peers
Other companies within the same industry or sector that are comparable to IOL Chemicals and Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Sharda Cropchem Ltd | 827.85 | -1.21 | 24.54 | 823.08 | 337.37 | 1.09 |
| Amines and Plasticizers Ltd | 248.30 | -1.33 | 33.33 | 501.95 | 372.61 | 0.20 |
| Indogulf Cropsciences Ltd | 107.02 | -1.26 | 0.00 | 214.56 | 44.66 | 0.00 |
| Grauer and Weil (India) Ltd | 115.60 | 0.00 | 33.31 | 2068.24 | 346.66 | 0.43 |
Company Info
2003 -Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges. -Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million. 2004 -Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors. 2007 - Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd. 2008 -IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004 -IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. 2009 -Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company -IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, -IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country. -IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation 2010 -IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010 2011 -IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011 2012 -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012 2013 -IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013" 2014 -IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014". 2015 -IOLCP to launch API business in US market -IOL Chemicals completes De-bottlenecking project 2020 -IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition 2021 - IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen 2024 -Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company. -IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company.
2003 -Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges. -Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million. 2004 -Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors. 2007 - Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd. 2008 -IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004 -IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. 2009 -Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company -IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, -IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country. -IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation 2010 -IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010 2011 -IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011 2012 -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012 2013 -IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013" 2014 -IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014". 2015 -IOLCP to launch API business in US market -IOL Chemicals completes De-bottlenecking project 2020 -IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition 2021 - IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen 2024 -Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company. -IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company.
Read More
Parent Organisation
IOL Chemicals and Pharmaceuticals Ltd.
Founded
29/09/1986
Managing Director
Mr.Varinder Gupta
NSE Symbol
IOLCPEQ
FAQ
The current price of IOL Chemicals and Pharmaceuticals Ltd is ₹ 91.18.
The 52-week high for IOL Chemicals and Pharmaceuticals Ltd is ₹ 94.39 and the 52-week low is ₹ 90.85.
The market capitalization of IOL Chemicals and Pharmaceuticals Ltd is currently ₹ 2676.38. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy IOL Chemicals and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in IOL Chemicals and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase IOL Chemicals and Pharmaceuticals Ltd shares.
The CEO of IOL Chemicals and Pharmaceuticals Ltd is Mr.Varinder Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
